English | Español

Biospace
Patient Daily | Jan 27, 2026

Novo Nordisk sees strong initial uptake for oral Wegovy amid rising competition
Patient Daily | Jan 27, 2026

Galapagos CEO outlines strategy shift after winding down cell therapy operations
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
Patient Daily | Jan 27, 2026

Biotech firms emphasize regulatory alignment amid ongoing uncertainty after recent FDA reversals
Patient Daily | Jan 27, 2026

Baseline Therapeutics launches phase III trials targeting addiction with GLP-1 drug
Patient Daily | Jan 27, 2026

Biopharma leaders express optimism at JPM26 despite absence of major deals
Patient Daily | Jan 26, 2026

Rare disease biotechs face loss if priority review voucher program remains lapsed
Patient Daily | Jan 26, 2026

Five experimental treatments could reshape future care for Parkinson's disease

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures